NCT06126003 - Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions

Breast Cancer

Interventions

OTHER

Observation

No Intervention

Trial Locations (6)

Cayuga Medical Center, Ithaca

Toledo Clinic Cancer Center, Toledo

Cancer Care Specialists of Illinois, Decatur

Valley Cancer Associates, PA, Harlingen

OptumCare Cancer Care, Las Vegas

New Jersey Cancer Care, PA, Belleville